Colonic stents versus diverting stoma for malignant left-sided colorectal obstruction show similar long-term oncologic results.
This single-center retrospective cohort study evaluated long-term oncologic outcomes in patients treated for malignant left-sided colorectal obstruction. The study population included 24 patients treated with colonic stents and 32 patients who underwent a diverting stoma. The primary outcome was cumulative 5-year overall survival, while secondary outcomes included 30-day complications, stent-related perforation, local recurrence, and median time from acute treatment to resection surgery. Follow-up duration was 5 years.
Regarding the primary outcome, cumulative 5-year overall survival was 63% in the stent group compared to 77% in the stoma group. The difference was not statistically significant (p = 0.319). For the secondary outcome of median time from acute treatment of obstruction to resection surgery, the duration was 30 days in the stent group and 55 days in the stoma group. There were no differences between the two groups regarding 30-day complications.
Safety analysis revealed a stent-related perforation rate of 1/24 (4.2%) in the stent group. Local recurrence occurred in two cases in the stent group and two cases in the stoma group (p = 1.0). The study authors noted that the lack of significant difference in survival may be due to a type II error, as larger studies are needed to confirm these results.